IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Partners Management LP

Q1 2020 Holdings

Filed 2020-05-15 | 52 holdings | $168.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-06-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biogen Inc(BIIB)ACOM09062X103$19.6M62,00011.7%
Biomarin Pharmaceutical Inc(BMRN)ACOM09061G101$25.5M302,00015.2%
Abbvie Inc(ABBV)ACOM00287Y109$36.3M477,00021.6%
PreviousPage 2 of 2